Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renato Cozzi

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Medicina (Kaunas, Lithuania)|June 24, 2022
Clinical Management of Acromegaly: Therapeutic Frontiers and New Perspectives for Somatostatin Receptor Ligands (SRLs)Alessandro Brunetti, Simone Antonini, Andrea Saladino, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|November 8, 2023
Case Report: Opposite Tumoral and Hormonal Responses to Low-dose Pasireotide in Cushing's DiseaseAndreea Liliana Serban, Benedetta Zampetti, Andrea Saladino, et al.
Case Reports in Endocrinology|February 28, 2022
A Tale of Two Hypersecreting Adrenal Neoplasms in the Heartland of COVID-19 Pandemic, Lombardy, ItalyBenedetta Zampetti, Roberto Attanasio, Emanuela Carioni, et al.
The Journal of Clinical Endocrinology and Metabolism|February 2, 2006
Primary treatment of acromegaly with octreotide LAR: a long-term (up to nine years) prospective study of its efficacy in the control of disease activity and tumor shrinkageRenato Cozzi, Marcella Montini, Roberto Attanasio, et al.
Frontiers in Endocrinology|February 16, 2024
Efficacy of pasireotide LAR for acromegaly: a prolonged real-world monocentric studyVittoria Favero, Benedetta Zampetti, Emanuela I Carioni, et al.
Cancers|February 13, 2025
Immunotherapy-Related Hypophysitis: A Narrative ReviewVincenza Di Stasi, Domenico La Sala, Renato Cozzi, et al.
The Journal of Clinical Endocrinology and Metabolism|November 3, 2005
Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegalyAnnamaria Colao, Roberto Attanasio, Rosario Pivonello, et al.
Frontiers in Endocrinology|November 17, 2025
From awareness to action: evolving endocrinologist practices in obesity treatment in ItalyMarco Chianelli, Luca Busetto, Roberto Attanasio, et al.
The Journal of Clinical Endocrinology and Metabolism|November 7, 2003
Lanreotide 60 mg, a new long-acting formulation: effectiveness in the chronic treatment of acromegalyRoberto Attanasio, Roberto Baldelli, Rosario Pivonello, et al.
The Journal of Clinical Endocrinology and Metabolism|July 5, 2003
Four-year treatment with octreotide-long-acting repeatable in 110 acromegalic patients: predictive value of short-term results?Renato Cozzi, Roberto Attanasio, Marcella Montini, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Medicina (Kaunas, Lithuania)|June 24, 2022
Clinical Management of Acromegaly: Therapeutic Frontiers and New Perspectives for Somatostatin Receptor Ligands (SRLs)Alessandro Brunetti, Simone Antonini, Andrea Saladino, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|November 8, 2023
Case Report: Opposite Tumoral and Hormonal Responses to Low-dose Pasireotide in Cushing's DiseaseAndreea Liliana Serban, Benedetta Zampetti, Andrea Saladino, et al.
Case Reports in Endocrinology|February 28, 2022
A Tale of Two Hypersecreting Adrenal Neoplasms in the Heartland of COVID-19 Pandemic, Lombardy, ItalyBenedetta Zampetti, Roberto Attanasio, Emanuela Carioni, et al.
The Journal of Clinical Endocrinology and Metabolism|February 2, 2006
Primary treatment of acromegaly with octreotide LAR: a long-term (up to nine years) prospective study of its efficacy in the control of disease activity and tumor shrinkageRenato Cozzi, Marcella Montini, Roberto Attanasio, et al.
Frontiers in Endocrinology|February 16, 2024
Efficacy of pasireotide LAR for acromegaly: a prolonged real-world monocentric studyVittoria Favero, Benedetta Zampetti, Emanuela I Carioni, et al.
Cancers|February 13, 2025
Immunotherapy-Related Hypophysitis: A Narrative ReviewVincenza Di Stasi, Domenico La Sala, Renato Cozzi, et al.
The Journal of Clinical Endocrinology and Metabolism|November 3, 2005
Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegalyAnnamaria Colao, Roberto Attanasio, Rosario Pivonello, et al.
Frontiers in Endocrinology|November 17, 2025
From awareness to action: evolving endocrinologist practices in obesity treatment in ItalyMarco Chianelli, Luca Busetto, Roberto Attanasio, et al.
The Journal of Clinical Endocrinology and Metabolism|November 7, 2003
Lanreotide 60 mg, a new long-acting formulation: effectiveness in the chronic treatment of acromegalyRoberto Attanasio, Roberto Baldelli, Rosario Pivonello, et al.
The Journal of Clinical Endocrinology and Metabolism|July 5, 2003
Four-year treatment with octreotide-long-acting repeatable in 110 acromegalic patients: predictive value of short-term results?Renato Cozzi, Roberto Attanasio, Marcella Montini, et al.
Pageof 5